As mRNA biotechnology matures, few firms have demonstrated a shift as dynamic as Moderna. Widely recognised […]
Japan’s IVD sector remains highly structured and closely governed, benefiting from a mature healthcare infrastructure and […]
Navigating Japan’s life sciences sector successfully hinges on more than just excellent science or a meticulously […]
The rise of Cell and Gene Therapies (CGT) marks a significant advancement in modern medicine, offering […]
The medical device industry demands the highest standards of quality and safety for its poducts. ISO […]
Overview: Introduction Six-month review process priority registration expanded PMDA support innovative drug consultation early application feedback […]
In the dynamic and ever-evolving field of oncology, Tumor-Infiltrating Lymphocytes (TILs) represent the latest in innovation […]
Japanese Market Opportunities in AI-Driven Elderly Care: Living, Health, and Medication Management The silver economy of […]
A Thriving Landscape in Japan’s Pharma Sector Pharma Japan and Strategic Opportunities are plentiful in Japan. […]
Japan’s Bioeconomy Strategy 2030 marks a transformative approach to integrating biotechnology into Japan’s economic fabric. It’s […]